HCA Healthcare, Inc. $HCA Shares Sold by Maj Invest Holding A S

Maj Invest Holding A S lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,225 shares of the company’s stock after selling 3,261 shares during the period. HCA Healthcare accounts for about 4.3% of Maj Invest Holding A S’s investment portfolio, making the stock its 12th largest position. Maj Invest Holding A S’s holdings in HCA Healthcare were worth $97,820,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. BlackRock Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at $5,069,974,000. Wellington Management Group LLP boosted its holdings in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the last quarter. Darsana Capital Partners LP grew its position in shares of HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Legal & General Group Plc purchased a new position in shares of HCA Healthcare during the second quarter valued at about $410,992,000. Finally, Jupiter Topco LLC bought a new stake in shares of HCA Healthcare in the second quarter worth about $371,138,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $463.10 on Thursday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The business’s 50 day moving average is $434.70 and its two-hundred day moving average is $444.88. The stock has a market capitalization of $100.26 billion, a P/E ratio of 15.50, a PEG ratio of 1.58 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. During the same period last year, the company earned $6.96 earnings per share. HCA Healthcare’s revenue was up 3.6% on a year-over-year basis. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.45%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported third-quarter adjusted earnings of $7.22 per share and revenue of $19.85 billion, exceeding Wall Street estimates of $6.65 per share and $19.33 billion, respectively. Revenue increased 3.6% year over year, supported by higher admissions and emergency-room visits. HCA Healthcare beats quarterly profit estimates on demand for medical services
• Positive Sentiment: TD Cowen raised its price target from $460 to $486 and assigned a “buy” rating, while KeyCorp increased its target from $435 to $490 and upgraded its view to “overweight.” The revisions suggest analysts see upside after the earnings report. TD Cowen recommendations KeyCorp recommendations
• Positive Sentiment: The company declared a quarterly dividend of $0.78 per share, equivalent to $3.12 annually and a 0.7% indicated yield, reinforcing shareholder returns.
• Neutral Sentiment: HCA remains one of the largest U.S. health systems by net patient revenue, underscoring its scale and market presence. 10 largest health systems by net patient revenue
• Negative Sentiment: Investors were unsettled by management’s signal that 2027 earnings could be broadly flat, partly because of declining Medicaid payments. HCA also expects a roughly $400 million impact from rising uninsured patients, while payer-mix pressure and higher costs weigh on margins.
• Negative Sentiment: Some operating trends were softer: ambulatory surgery-center volume declined 5.4%, and fewer surgeries tempered otherwise strong admission growth. Baird raised its target to $409 but maintained a “neutral” rating, implying a valuation risk at current levels. HCA earnings reveal 5.4% ASC volume drop

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Morgan Stanley decreased their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a report on Monday, July 27th. Mizuho set a $495.00 target price on HCA Healthcare in a research report on Wednesday. Leerink Partners reissued an “outperform” rating and issued a $492.00 target price on shares of HCA Healthcare in a report on Friday, September 18th. Finally, Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $474.00.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.